IJMS | Free Full-Text | Generation and Characterization of a Polyclonal Human Reference Antibody to Measure Anti-Drug Antibody Titers in Patients with Fabry Disease
Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain | Scientific Reports
Gyrolab ADA Solution | Automated Immunoassays
US Food & Drug Administration Perspective on Immunogenicity
Genome-wide pharmacogenetics of anti-drug antibody response to bococizumab highlights key residues in HLA DRB1 and DQB1 | Scientific Reports
Assay signal as an alternative to titer for assessment of magnitude of an antidrug antibody response | Bioanalysis
Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine - James M Martinez, Nada Hindiyeh, Greg Anglin, Kavita Kalidas, Michael E Hodsdon, William Kielbasa, Brian A
Anti-Drug Antibody Assays with Next Generation Protein Sequencing
Boxplot of positive ADA titer results by visit and treatment (safety... | Download Scientific Diagram
Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium | The AAPS Journal
ADA Quantification Assays - Creative Biolabs
Drug Concentrations and Anti-drug Antibodies Influence in Response to Adalimumab: Results from the BioEfficacySpA Clinical Trial - ACR Meeting Abstracts
Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies - ScienceDirect
Effect of maximum ADA titer results on ACR20 response rate and mean... | Download Scientific Diagram
Immunogenicity testing of biotherapeutics | FyoniBio
A systematic examination of anti-drug antibody titer estimation: Applied recommendations - ScienceDirect
Heat pre-treatment can abolish anti-drug antibody interference in ligand binding pharmacokinetic assays | AAPS Open | Full Text
Assay signal as an alternative to titer for assessment of magnitude of an antidrug antibody response | Bioanalysis
Frontiers | Assessment and impact of dose escalation on anti-drug antibodies in Fabry disease
Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium | The AAPS Journal
Optimizing PK/ADA assays with anti-idiotype antibodies
ADA titer analyses. (a) Atezolizumab concentration by ADA titer and (b)... | Download Scientific Diagram
Antibodies against recombinant enzyme in the treatment of Fabry disease: Now you see them, now you don't: Molecular Therapy Methods & Clinical Development
Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium | The AAPS Journal
